Summary Information:
Vor Biopharma Inc. Common Stock
NASDAQ:VOR


email
admin@troach.net
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


Vor Biopharma Inc. Common Stock
Exchange: NASDAQ
Symbol: VOR
SEC CIK: 0001817229
Phone: 617-655-6580
215 FIRST STREET
SUITE 430
CAMBRIDGE MA 02142
CEO:
Price when page updated: 1.86 Date: 2023-12-02
Company Website:
www.vorbiopharma.com

_Description: Vor Biopharma is a cell therapy company that aims to transform the lives of cancer patients by pioneering engineered hematopoietic stem cell (eHSC) therapies to create next-generation, treatment-resistant transplants that unlock the potential of targeted therapies. By removing biologically redundant proteins from eHSCs, we design these cells and their progeny to be treatment-resistant to complementary targeted therapies, thereby enabling these therapies to selectively destroy cancerous cells while sparing healthy cells.

IPO YEAR:
2021
Sector:
Health Care
Industry:
Biotechnology: Pharmaceutical Preparations
ADRTSO:

MarketCap:
126118578.00
Beta:

52 Week High:
63.62
52 Week Low:
10.48
52 Week Change:
-0.6901333333333334
Short Interest:

Short Date:

Shares Outstanding:
37289504
Dividend Rate:
0
Dividend Yield:
6.85%
ExDividend Date:

Latest EPS:

Latest EPS Date:
15 Nov 2022
Float:
0
return on Equity:
-39.70%
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
€22.311B
ttmEPS:
0
Revenue:
€45.580B
Gross Profit:

Cash:

Debt:

Institution Percent:
82.30%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
10.65%
Return on Assets:
-33.80%
Return on Capital:

Profit Margin:
-
Price to Sales:
-
Price To Book:
1.03
Short Ratio:
16.53
PE Ratio:
0
Employees:
88
1Y Guesstimate
13.800:2.0:5




__The following are links to various summary and news pages for
__Vor Biopharma Inc. Common Stock [ VOR ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-12-02